• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[联合全肝切除术、原位肝移植术和胰十二指肠切除术治疗不可切除的肝门部胆管癌]

[Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].

作者信息

He Xiao-shun, Zhang Shao, Zhu Xiao-feng, Ji Yong, Zeng Ji-xiao, Ma Yi, Wang Dong-ping, Ju Wei-qiang, Wu Lin-wei, Li Zhi, Huang Jie-fu

机构信息

Organ Transplantation Center of the First Affiliated Hospital, SUN Yat-Sen University, Guangzhou 510080, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2006 Mar 1;44(5):302-5.

PMID:16635386
Abstract

OBJECTIVE

To explore the feasibility and outcome of combined hepatectomy, orthotopic liver transplantation and Whipple's pancreatoduodenectomy for radical excision of cholangiocarcinoma.

METHODS

A 35-year-old female patient with unresectable cholangiocarcinoma underwent curative radical operation, which includes hepatectomy, orthotopic liver transplantation and pancreaticoduodenectomy of hilar bile duct carcinoma; immunosuppression followed an induction protocol with FK506 and steroids. Lamivudine and HBIg were used to prevent hepatitis B virus from infection again.

RESULTS

Pathologic examination revealed low differentiated cholangiocarcinoma and immunohistochemistry stains demonstrated positive expression of cytokeratin 9 and 17, carcinoembryonic antigen and the hepatocyte protein was negative. Neither the margins of resection nor the periductal lymph nodes were involved. The liver showed evidence of cholestasis and metastasis nod. The patient was hospitalized 32 days and came back to the previous work. He has been followed up for more than 14 months up to now and is currently alive without any evidence of recurrent cancer.

CONCLUSIONS

For some selected unresectable Klatskin's tumors, combined hepatectomy, pancreatoduodenectomy and orthotopic liver transplantation was justified. The radical methods maybe provide long-time survival and curative effect. Nevertheless, because of possible tumor recurrence and ethical controversy, the combined hepatectomy, pancreatoduodenectomy and orthotopic liver transplantation procedure has to be applied only with caution and indications.

摘要

目的

探讨联合肝切除术、原位肝移植术和惠普尔胰十二指肠切除术根治性切除胆管癌的可行性及疗效。

方法

一名35岁不可切除胆管癌女性患者接受了根治性手术,包括肝切除术、原位肝移植术及肝门部胆管癌胰十二指肠切除术;采用FK506和类固醇进行诱导免疫抑制。使用拉米夫定和乙肝免疫球蛋白预防乙肝病毒再次感染。

结果

病理检查显示为低分化胆管癌,免疫组化染色显示细胞角蛋白9和17、癌胚抗原呈阳性表达,肝细胞蛋白呈阴性。切缘及胆管周围淋巴结均未受累。肝脏有胆汁淤积和转移结节迹象。患者住院32天,恢复至术前工作状态。截至目前已随访14个月以上,患者存活,无癌症复发迹象。

结论

对于一些选定的不可切除的肝门部肿瘤,联合肝切除术、胰十二指肠切除术和原位肝移植术是合理的。这种根治性方法可能提供长期生存和疗效。然而,由于可能存在肿瘤复发及伦理争议,联合肝切除术、胰十二指肠切除术和原位肝移植术必须谨慎应用并严格掌握适应证。

相似文献

1
[Combined total hepatectomy, orthotopic liver transplantation and pancreatoduodenectomy for unresectable hilar bile duct carcinoma].[联合全肝切除术、原位肝移植术和胰十二指肠切除术治疗不可切除的肝门部胆管癌]
Zhonghua Wai Ke Za Zhi. 2006 Mar 1;44(5):302-5.
2
Combined adult-to-adult living donor right lobe liver transplantation and pancreatoduodenectomy for distal bile duct adenocarcinoma in a patient with primary sclerosing cholangitis.成人对成人活体供肝右叶肝移植联合胰十二指肠切除术治疗原发性硬化性胆管炎患者的远端胆管腺癌
J Am Coll Surg. 2003 Nov;197(5):765-9. doi: 10.1016/j.jamcollsurg.2003.06.001.
3
Hepatopancreatoduodenectomy could be allowed for patients with advanced intrahepatic cholangiocarcinoma.对于晚期肝内胆管癌患者可考虑行肝胰十二指肠切除术。
Hepatogastroenterology. 2007 Mar;54(74):346-9.
4
[Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma].[肝切除-惠普尔整块切除术联合原位肝移植治疗早期肝门部胆管癌放疗后的长期无瘤生存]
Zhonghua Wai Ke Za Zhi. 2009 Aug 1;47(15):1155-61.
5
[Two cases of lower bile duct recurrence resected by pancreatoduodenectomy after hepatectomy for hilar cholangiocarcinoma].肝门部胆管癌肝切除术后胰十二指肠切除术治疗低位胆管复发2例
Gan To Kagaku Ryoho. 2012 Nov;39(12):2119-21.
6
Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.肝切除-惠普尔整块切除联合原位肝移植治疗早期肝门部胆管癌放疗后的长期无瘤生存
Liver Transpl. 2008 Mar;14(3):279-86. doi: 10.1002/lt.21287.
7
Resection of hilar cholangiocarcinoma: concomitant liver resection decreases hepatic recurrence.肝门部胆管癌切除术:同期肝切除可降低肝内复发率。
Ann Surg. 2008 Aug;248(2):273-9. doi: 10.1097/SLA.0b013e31817f2bfd.
8
Orthotopic liver transplantation with hepatopancreatoduodenectomy for hilar cholangiocarcinoma.肝门部胆管癌根治性切除联合原位肝移植术
Chin Med J (Engl). 2007 Feb 5;120(3):251-3.
9
Neoadjuvant therapy protocol and liver transplantation in combination with pancreatoduodenectomy for the treatment of hilar cholangiocarcinoma occurring in a case of primary sclerosing cholangitis: case report with a more than 8-year disease-free survival.新辅助治疗方案联合肝移植及胰十二指肠切除术治疗原发性硬化性胆管炎患者的肝门部胆管癌:病例报告及超过8年的无病生存期
Transplant Proc. 2011 May;43(4):1187-9. doi: 10.1016/j.transproceed.2011.01.140.
10
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinoma.肝细胞癌合并胆管癌患者的外科治疗及预后
Ann Surg Oncol. 2009 Mar;16(3):623-9. doi: 10.1245/s10434-008-0278-3. Epub 2009 Jan 6.